These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34716158)

  • 1. Is improvement in indicators of women's empowerment associated with uptake of WHO recommended IPTp-SP levels in sub-Saharan Africa? A multilevel approach.
    Ameyaw EK; Njue C; Amoah RM; Appiah F; Baatiema L; Ahinkorah BO; Seidu AA; Ganle JK; Yaya S
    BMJ Open; 2021 Oct; 11(10):e047606. PubMed ID: 34716158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in Uganda: a national survey.
    Ameyaw EK
    Malar J; 2022 Oct; 21(1):285. PubMed ID: 36207727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya.
    Mutanyi JA; Onguru DO; Ogolla SO; Adipo LB
    Infect Dis Poverty; 2021 Aug; 10(1):106. PubMed ID: 34362443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
    Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
    PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-based strategies to increase coverage of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in sub-Saharan Africa: a systematic review, meta-analysis, meta-ethnography, and economic assessment.
    Koita K; Kayentao K; Worrall E; Van Eijk AM; Hill J
    Lancet Glob Health; 2024 Sep; 12(9):e1456-e1469. PubMed ID: 39151981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The readiness of malaria services and uptake of intermittent preventive treatment in pregnancy in six sub-Saharan countries.
    Xu X; Liang D; Zhao J; Mpembeni R; Olenja J; Yam EL; Huang J
    J Glob Health; 2024 Jun; 14():04112. PubMed ID: 38939971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of four or more doses of sulfadoxine pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Zambia: findings from the 2018 malaria in pregnancy survey.
    Sinyange D; Mukumbuta N; Mutale LS; Mumbole H; Hamainza B; Sialubanje C
    BMJ Open; 2023 May; 13(5):e073287. PubMed ID: 37236665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Andersen's behavioral model of health care use for intermittent preventive treatment of malaria in pregnancy in Nigeria.
    Solanke BL; Yinusa RA; Oyeleye OJ; Oluwatope OB; Ilesanmi BB; Oni TO
    BMC Pregnancy Childbirth; 2023 May; 23(1):315. PubMed ID: 37142948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015.
    Oppong FB; Gyaase S; Zandoh C; Nettey OEA; Amenga-Etego S; Anane EA; Adda R; Dosoo DK; Owusu-Agyei S; Asante KP
    BMJ Open; 2019 Jun; 9(6):e027946. PubMed ID: 31230017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socio-demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013.
    Olugbade OT; Ilesanmi OS; Gubio AB; Ajayi I; Nguku PM; Ajumobi O
    Pan Afr Med J; 2019; 32(Suppl 1):13. PubMed ID: 30949287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's empowerment and uptake of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy: results from a cross-sectional baseline survey in the Lake endemic region, Kenya.
    Odwe G; Matanda DJ; Zulu T; Kizito S; Okoth O; Kangwana B
    Malar J; 2023 Aug; 22(1):241. PubMed ID: 37612754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO antenatal care policy and prevention of malaria in pregnancy in sub-Saharan Africa.
    Olapeju B; Bride M; Gutman JR; Wolf K; Wabwire S; Atobrah D; Babanawo F; Akrofi OO; Atta-Obeng C; Soro BK; Touré F; Shekarau E; Hendrickson ZM
    Malar J; 2024 Jul; 23(1):218. PubMed ID: 39044194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of country adoption and implementation of the 2012 WHO recommendations for intermittent preventive treatment for pregnant women in sub-Saharan Africa.
    Henry M; Florey L; Youll S; Gutman JR
    Malar J; 2018 Oct; 17(1):364. PubMed ID: 30326904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
    Yaya S; Kota K; Buh A; Bishwajit G
    BMC Public Health; 2019 Nov; 19(1):1467. PubMed ID: 31694607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
    Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
    Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.